Deep Track Capital, LP 13F holdings, Q3 2024
Holdings as of September 30, 2024 · filings on SEC EDGAR · latest filing →
Deep Track Capital, LP disclosed 69 US equity positions worth $3.1bn in its Q3 2024 13F filing. The largest position was ARGX at 6.3% of the reported book, followed by DVAX and GH.
What did Deep Track Capital, LP own in Q3 2024? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs prior |
|---|---|---|---|---|---|---|---|
| 1 | ARGX ARGENX SE | Healthcare | 6.3% | $197.9m | 365,000 | – | |
| 2 | DVAX DYNAVAX TECHNOLOGIES CORP | 4.5% | $139.5m | 12,526,486 | – | ||
| 3 | GH GUARDANT HEALTH INC | Healthcare | 4.4% | $137.7m | 6,000,560 | – | |
| 4 | APLSUSD APELLIS PHARMACEUTICALS INC | 4.1% | $126.9m | 4,400,654 | – | ||
| 5 | IMVT IMMUNOVANT INC | Healthcare | 4.0% | $123.9m | 4,347,464 | – | |
| 6 | SWTXUSD SPRINGWORKS THERAPEUTICS INC | 3.9% | $123.2m | 3,843,900 | – | ||
| 7 | DYN DYNE THERAPEUTICS INC | Healthcare | 3.8% | $117.9m | 3,282,000 | – | |
| 8 | ITCIEUR INTRA-CELLULAR THERAPIES INC | 3.7% | $117.1m | 1,600,693 | – | ||
| 9 | OCUL OCULAR THERAPEUTIX INC | Healthcare | 3.5% | $110.7m | 12,721,460 | – | |
| 10 | NTLA INTELLIA THERAPEUTICS INC | Healthcare | 3.2% | $101.7m | 4,950,000 | – | |
| 11 | ALKS ALKERMES PLC | Healthcare | 3.1% | $98.0m | 3,500,000 | – | |
| 12 | VRNA VERONA PHARMA PLC | 2.9% | $91.5m | 3,180,025 | – | ||
| 13 | IONS IONIS PHARMACEUTICALS INC | Healthcare | 2.8% | $88.1m | 2,200,000 | – | |
| 14 | NRIX NURIX THERAPEUTICS INC | Healthcare | 2.8% | $86.9m | 3,868,104 | – | |
| 15 | VRDN VIRIDIAN THERAPEUTICS INC | Healthcare | 2.7% | $85.3m | 3,750,945 | – | |
| 16 | BCYC BICYCLE THERAPEUTICS PLC | Healthcare | 2.6% | $80.3m | 3,548,001 | – | |
| 17 | MBX MBX BIOSCIENCES INC | Healthcare | 2.5% | $78.4m | 3,018,935 | – | |
| 18 | AXSM AXSOME THERAPEUTICS INC | Healthcare | 2.5% | $77.0m | 857,219 | – | |
| 19 | PLRX PLIANT THERAPEUTICS INC | Healthcare | 2.1% | $66.9m | 5,972,257 | – | |
| 20 | APGE APOGEE THERAPEUTICS INC | Healthcare | 1.9% | $58.7m | 1,000,000 | – | |
| 21 | AUTL AUTOLUS THERAPEUTICS PLC | Healthcare | 1.8% | $55.4m | 15,272,172 | – | |
| 22 | GPCR STRUCTURE THERAPEUTICS INC | Healthcare | 1.7% | $53.6m | 1,220,508 | – | |
| 23 | OLMA OLEMA PHARMACEUTICALS INC | Healthcare | 1.5% | $47.8m | 4,000,000 | – | |
| 24 | 430 TERNS PHARMACEUTICALS INC | 1.5% | $46.5m | 5,576,558 | – | ||
| 25 | FDMT 4D MOLECULAR THERAPEUTICS IN | 1.4% | $44.3m | 4,096,452 | – | ||
| 26 | ABVX ABIVAX SA | 1.3% | $41.2m | 3,579,209 | – | ||
| 27 | TGTX TG THERAPEUTICS INC | Healthcare | 1.3% | $40.3m | 1,725,000 | – | |
| 28 | BRD1EUR MIND MEDICINE MINDMED INC | 1.3% | $40.2m | 7,065,099 | – | ||
| 29 | KURA KURA ONCOLOGY INC | Healthcare | 1.2% | $38.4m | 1,963,505 | – | |
| 30 | GERN GERON CORP | Healthcare | 1.1% | $34.4m | 7,575,049 | – | |
| 31 | CYTK CYTOKINETICS INC | Healthcare | 1.1% | $33.3m | 629,906 | – | |
| 32 | ORKA ORUKA THERAPEUTICS INC | Healthcare | 1.0% | $30.3m | 1,235,187 | – | |
| 33 | ANIP ANI PHARMACEUTICALS INC | Healthcare | 1.0% | $30.1m | 504,828 | – | |
| 34 | SYRE SPYRE THERAPEUTICS INC | 0.9% | $29.4m | 1,000,000 | – | ||
| 35 | EWTX EDGEWISE THERAPEUTICS INC | 0.9% | $29.4m | 1,100,536 | – | ||
| 36 | KYMR KYMERA THERAPEUTICS INC | Healthcare | 0.9% | $28.4m | 600,326 | – | |
| 37 | KRRO KORRO BIO INC | Healthcare | 0.9% | $28.4m | 850,000 | – | |
| 38 | RNAGBP AVIDITY BIOSCIENCES INC | 0.7% | $21.8m | 475,000 | – | ||
| 39 | CNTA CENTESSA PHARMACEUTICALS PLC | 0.7% | $21.6m | 1,350,000 | – | ||
| 40 | ALEC ALECTOR INC | Healthcare | 0.7% | $21.6m | 4,631,998 | – | |
| 41 | NKTR NEKTAR THERAPEUTICS | Healthcare | 0.7% | $20.7m | 15,922,655 | – | |
| 42 | ETNBGBP 89BIO INC | 0.7% | $20.5m | 2,766,512 | – | ||
| 43 | BCAX BICARA THERAPEUTICS INC | 0.6% | $20.3m | 796,852 | – | ||
| 44 | AKERO THERAPEUTICS INC | 0.6% | $19.8m | 689,784 | – | ||
| 45 | FATE FATE THERAPEUTICS INC | Healthcare | 0.6% | $19.5m | 5,572,607 | – | |
| 46 | SLN SILENCE THERAPEUTICS PLC | 0.6% | $18.2m | 1,000,000 | – | ||
| 47 | ENGENE HOLDINGS INC | 0.5% | $17.2m | 2,607,633 | – | ||
| 48 | EDIT EDITAS MEDICINE INC | Healthcare | 0.5% | $16.7m | 4,900,334 | – | |
| 49 | XNCR XENCOR INC | Healthcare | 0.5% | $16.1m | 800,000 | – | |
| 50 | PYXS PYXIS ONCOLOGY INC | 0.5% | $15.4m | 4,184,100 | – |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.